REDSTEM: Reduced-Dose Versus Full-Dose Alteplase for High-Risk Pulmonary Embolism (clinicaltrials.gov) - Sep 15, 2026 - P4 | N=400 | Not yet recruiting | Sponsor: Sahlgrenska University Hospital
New P4 trial • Cardiovascular • Pulmonary Embolism • Respiratory Diseases
|